Second Remission

Second Remission is a clinical state in oncology, specifically within the context of relapsed disease, denoting the restoration of disease control or absence of detectable malignancy following successful re-induction therapy after a prior relapse.

535

Publications

29.2K

Citations

3.7K

Authors

1.2K

Institutions

Publications per year

2017–2026

79

Authors

3.7K

  1. ML
    Myriam Labopin

    Sorbonne Université, France

    15 publications · 578 citations

    14

    h-index

  2. MM
    Mohamad Mohty

    Sorbonne Université, France

    13 publications · 520 citations

    13

    h-index

  3. DJ
    Daniel J. Weisdorf

    University of Minnesota, United States

    12 publications · 1.1K citations

    12

    h-index

  4. AN
    Arnon Nagler

    Sheba Medical Center, Israel

    11 publications · 439 citations

    11

    h-index

  5. BM
    Bruce M. Camitta

    Medical College of Wisconsin, United States

    9 publications · 706 citations

    9

    h-index

1–5 of 3.7K

Venues

  1. Journal of Clinical Oncology

    38 publications · 4.6K citations

    33

    h-index

  2. British Journal of Haematology

    BJH · 58 publications · 2.4K citations

    29

    h-index

  3. Cancer

    40 publications · 2.1K citations

    28

    h-index

  4. Biology of Blood and Marrow Transplantation

    TCT · 25 publications · 1.4K citations

    21

    h-index

  5. Medical and Pediatric Oncology

    27 publications · 1.1K citations

    20

    h-index

1–5